Medicare does not routinely cover coronary artery calcium (CAC) scans when ordered as a screening test for heart disease risk. Most people who want one pay out of pocket, typically somewhere between $75 and $300 depending on the facility. The situation is more complicated than a flat “no,” though, because coverage decisions for cardiac CT rest with local Medicare contractors rather than a single national policy, and the disconnect between what cardiology guidelines recommend and what insurers actually pay for has frustrated physicians and patients for years.
Why Medicare Does Not Cover CAC Screening
The core issue traces back to how the U.S. Preventive Services Task Force (USPSTF) evaluates screening tests. The USPSTF concluded that the evidence is insufficient to determine whether adding a CAC score to traditional risk assessment in asymptomatic adults improves outcomes enough to justify the test on a population level.1JAMA. Final Recommendation Statement: Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors That “I” rating (meaning insufficient evidence, not a recommendation against) carries enormous weight because Medicare is generally required to cover preventive services that receive an “A” or “B” recommendation from the USPSTF. A test graded “I” has no such mandate.
The Centers for Medicare & Medicaid Services (CMS) once attempted to implement a national noncoverage determination for cardiac CT, which would have explicitly blocked payment across the board. After pushback from cardiology and radiology organizations, CMS withdrew that proposal. As a result, coverage decisions for cardiac CT, including CAC scoring, remain at the discretion of individual local Medicare Administrative Contractors (MACs).2Elsevier / ScienceDirect (Journal of the American College of Radiology). Cardiac CT and Coronary CTA: Early Medicare Claims Analysis of National and Regional Utilization and Coverage In practice, most MACs do not cover CAC screening for asymptomatic patients. Some may cover it in narrow diagnostic scenarios where a patient already has symptoms suggestive of coronary artery disease, but even that varies by region.
The result is a patchwork. Where you live and which MAC handles your claims can influence whether you have any shot at coverage. But the realistic expectation for most Medicare beneficiaries seeking a CAC scan purely for risk stratification is that they will pay the full cost themselves.
What Cardiology Guidelines Actually Recommend
Here is where the frustration sets in for many physicians. While the USPSTF has not endorsed CAC screening, major cardiology societies have. The 2018 American College of Cardiology/American Heart Association cholesterol guidelines recommend considering a CAC score for adults aged 40 to 75 who fall into an intermediate risk range and for whom the decision about starting a statin is not clear-cut.3Journal of Clinical Lipidology. NLA Scientific Statement on Coronary Artery Calcium Scoring: Key Points and Recommendations The National Lipid Association echoed this position, calling CAC scoring “reasonable” to guide discussions between clinicians and patients when risk-based decisions for statin therapy remain uncertain.
The tension between these two influential bodies matters because Medicare coverage frameworks hinge on the USPSTF, not on specialty society guidelines. A cardiologist might look at a borderline-risk 62-year-old and strongly recommend a CAC scan to decide on statin therapy, only for the patient to discover that Medicare will not help pay for it. The test that the treating physician considers best practice is treated by the insurance system as an elective luxury.
How Well the Test Actually Predicts Heart Disease
The evidence supporting CAC scoring as a predictor of future heart events is, frankly, stronger than for many tests that insurers cover without complaint. In a pooled analysis of large population-based studies, CAC score outperformed age alone in predicting coronary heart disease events, with meaningful improvements in correctly reclassifying people’s risk.4PubMed Central. Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies The test was especially useful among participants who later went on to have an event, helping to sort them into higher risk categories where they might have benefited from earlier intervention.
For older adults, a group that overlaps heavily with the Medicare population, the data is particularly compelling. One study found that the risk of coronary events climbed steeply with higher calcium scores: compared to people with low scores, those with scores above 1,000 had roughly eight times the risk of a coronary event after adjusting for traditional risk factors.5PubMed. Coronary calcification improves cardiovascular risk prediction in the elderly Another study in elderly patients found that CAC scoring powerfully reclassified people at intermediate risk into either high or low categories, essentially resolving the ambiguity that traditional risk calculators leave behind.6PubMed. Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study
When stacked against other risk enhancers recommended in the 2018 guidelines, such as family history markers or inflammatory biomarkers, CAC scoring came out on top. Individual risk enhancers provided little or no additional discrimination beyond standard risk calculators, while CAC reliably reclassified intermediate-risk participants, particularly those with fewer than three other risk enhancers.7PubMed Central. Prognostic Utility of Risk Enhancers and Coronary Artery Calcium Score Recommended in the 2018 ACC/AHA Multisociety Cholesterol Treatment Guidelines Over the Pooled Cohort Equation: Insights From 3 Large Prospective Cohorts This is one reason the lack of insurance coverage frustrates researchers: the evidence base for CAC’s predictive power is more robust than for many tests that are routinely reimbursed.
What Medicare Does Cover for Heart Disease Screening
If you are a Medicare beneficiary wondering about your heart, there are covered alternatives, though they serve somewhat different purposes. Medicare covers stress tests, including exercise treadmill testing, stress echocardiography, and nuclear stress imaging (single-photon emission CT, or SPECT), when ordered for diagnostic evaluation of symptoms like chest pain or shortness of breath. Coronary CT angiography (CCTA), which is a different and more detailed scan than a simple calcium score, has also seen growing use in the Medicare population, with its utilization relative to traditional nuclear imaging increasing substantially over the past decade.8Lippincott Journals / Circulation: Cardiovascular Imaging. Temporal Trends in Noninvasive and Invasive Cardiac Testing From 2010 to 2022 in the US Medicare Population
The key distinction is that these tests are generally covered when there is a diagnostic indication, meaning you already have symptoms or findings suggestive of heart disease. A CAC scan is most valuable in the opposite scenario: you feel fine, you have no symptoms, and you want to know whether silent plaque buildup changes what you should do about your cholesterol. That preventive framing is exactly what falls outside Medicare’s current coverage rules for this test.
Coverage policies for cardiac CT also vary between the U.S. and other countries. A cross-national comparison found that CCTA coverage policies in the United Kingdom were more permissive than in the United States, despite the U.S. having four times as many CT scanners per beneficiary.9PubMed Central. Cardiac coronary tomography angiography (CCTA) use across geographical regions in the USA and the UK: a cross-sectional study Significant regional variation existed within both countries, underscoring how much geography shapes access to cardiac imaging.
The Behavioral Payoff of Seeing Your Own Calcium Score
One argument for covering CAC scans that goes beyond pure prediction is the motivational effect. There is something visceral about being told you have visible calcium deposits in your coronary arteries. Research consistently shows that knowing your score changes behavior in ways that vague risk percentages do not.
A systematic review found that CAC screening enhanced medication adherence in the vast majority of studies examined.10PubMed. The effects of coronary artery calcium screening on behavioral modification, risk perception, and medication adherence among asymptomatic adults: a systematic review The pattern is intuitive: statin compliance was lowest among people with a zero calcium score and climbed steadily with higher scores, reaching roughly double the adherence rate among those with scores above 400 compared to those at zero.11PubMed. Motivational effects of coronary artery calcium scores on statin adherence and weight loss A randomized trial that unblinded participants to their CAC results found reductions in LDL cholesterol at 12 months regardless of whether patients continued statins, suggesting that the knowledge itself prompted broader improvements in risk factor control.12PubMed. Impact of a coronary artery calcium-guided statin treatment protocol on cardiovascular risk at 12 months: Results from a pragmatic, randomised controlled trial
From a practical standpoint, this means a CAC scan can serve double duty: it sharpens the clinical decision about whether to prescribe a statin, and it gives the patient a concrete, personal reason to take the pill (or, if the score is zero, a reason to feel reassured and possibly defer medication). Both outcomes have real value, though neither currently factors into Medicare’s coverage calculus.
Is a CAC Scan Worth Paying for Out of Pocket?
For many people the answer is yes, particularly if you fall into the intermediate-risk zone where the clinical decision about statin therapy genuinely could go either way. Cost-effectiveness analyses have generally been favorable toward CAC-guided strategies. In people with a family history of coronary disease, using CAC scores to guide statin decisions was cost-effective at well under commonly used willingness-to-pay thresholds, though the value was driven by specific subgroups: men, people over 60, and those with a 10-year risk of at least 7.5%. The same analysis found that scanning low-risk patients (under 5% ten-year risk) or younger adults in their forties was not cost-effective.13PubMed. Cost-Effectiveness of Coronary Artery Calcium Scoring in People With a Family History of Coronary Disease
Among adults with diabetes, a population at elevated cardiovascular risk, a modeling study using data from the Multi-Ethnic Study of Atherosclerosis found that using a CAC score of 100 or above as a threshold for initiating high-intensity statins and low-dose aspirin yielded reasonable cost-effectiveness, though simply treating all diabetic patients with statins regardless of CAC provided the greatest overall health gains.14PubMed Central. Cost-Effectiveness of Coronary Artery Calcium Scoring for Cardiovascular Disease Prevention in Diabetes: An Analysis From MESA The takeaway is that CAC scanning adds the most value when the treatment decision is genuinely uncertain. If you and your doctor would clearly start a statin regardless of the scan result, the test might not change your management enough to justify the cost.
At typical out-of-pocket prices in the range of $100 to $200, the financial barrier is lower than for many medical tests. Some health systems and imaging centers actively market low-cost CAC scans to attract self-pay patients, knowing that the clinical utility supports the expenditure even without insurance reimbursement.
Radiation Exposure and Safety
A CAC scan uses a low-dose, non-contrast CT protocol, and the radiation exposure is modest, though it varies more than you might expect depending on the machine and settings used. A study surveying protocols across multiple centers found that the effective dose from a single scan ranged from about 0.8 to 10.5 millisieverts, with a median around 2.3 millisieverts.15PubMed Central. Coronary artery calcification screening: estimated radiation dose and cancer risk For context, that median dose is roughly equivalent to a few months of natural background radiation. The tenfold range between the lowest and highest protocols, however, means it is reasonable to ask what protocol a facility uses, particularly if you are considering repeat scans down the road.
The estimated cancer risk from a single scan at these doses is extremely small on an individual level, though researchers have noted that population-level screening programs would need to weigh even tiny per-person risks multiplied across millions of scans. For an individual making a decision about whether to get one scan, the radiation concern is minimal compared to the potential benefit of better-informed heart disease prevention.
Repeat Scans and Tracking Changes Over Time
One question that comes up after a first CAC scan is whether and when to repeat it. Data show that increasing calcium scores on serial scans are associated with a worse prognosis, which suggests a potential role for re-scanning to evaluate whether risk is changing and whether treatment is working.16PubMed. Coronary artery calcium scanning: past, present, and future However, there are no firm guidelines about how often to repeat the test, and since even the initial scan is not covered by Medicare for most beneficiaries, repeat scans compound the out-of-pocket cost.
From a practical standpoint, the strongest case for a repeat scan is in someone whose initial result was ambiguous (a low but nonzero score) and who wants to know whether plaque is progressing several years later. A person with a score of zero has a very favorable prognosis that tends to persist for years, making an early repeat scan unnecessary. A person with a very high score already has a clear indication for aggressive risk factor management, making a repeat scan unlikely to change management.
Who Gets Scanned and Who Does Not
Because CAC scans are largely self-pay, access tilts heavily toward people who can afford the out-of-pocket cost and who have physicians aware of the test’s value. Research into who actually gets scanned reveals troubling disparities. One study found that White patients were over four times more likely to have a CAC scan performed than Black patients. Among those who did get scanned, Black patients with coronary calcification were less likely to receive follow-up cardiac care, and their adverse outcome rates were substantially higher over a median follow-up of about three and a half years, even after matching for underlying risk factors and calcium scores.17Journal of Clinical Lipidology. Racial Disparities in Access to Coronary Calcium Scoring and Downstream Cardiovascular Care and Events
Income plays a role as well. An analysis of patients who underwent CAC testing found they were predominantly White and English-speaking, with an average median household income significantly above the surrounding metropolitan area’s median.18PubMed. Sociodemographic Disparities in Coronary Artery Calcium Screening When a clinically valuable test is available mainly to those who can pay cash for it, the people most likely to benefit from early risk detection, including those in underserved communities with higher baseline cardiovascular risk, are the least likely to receive it. Insurance coverage, or the lack of it, is a direct contributor to that gap.
Incidental Findings on Cardiac CT
A CAC scan captures images of more than just the heart. The CT field of view includes the lungs, portions of the upper abdomen, and other chest structures, which means the scan sometimes reveals unexpected findings. The most common incidental finding is a pulmonary nodule, a small spot on the lung. In one study of patients undergoing coronary CT angiography, lung nodules were reported in about 28% of patients, though the vast majority of these were benign and required no further action under updated guidelines.19PubMed Central. Incidental Pulmonary Nodules in Emergent Coronary CT Angiography for Suspected Acute Coronary Syndrome: Impact of Revised 2017 Fleischner Society Guidelines A separate study following patients who had incidental lung nodules found on cardiac CT reported that none of the nodules in the group whose findings were read turned out to be malignant, though the notification triggered substantial additional imaging.20PubMed. Incidental pulmonary nodules on cardiac computed tomography: prognosis and use
This is worth knowing because an incidental finding can launch a cascade of follow-up tests, office visits, and anxiety, most of which will ultimately reveal nothing worrisome. In a Canadian cohort undergoing cardiac CT, lung nodules accounted for the largest share of incidental findings, and about a quarter of all extracardiac findings were flagged as significant enough to warrant follow-up.21PubMed Central. Incidental findings in CT imaging of coronary artery bypass grafts: results from a Canadian multicenter prospective cohort Updated radiology guidelines have reduced the number of nodules that require follow-up imaging, which helps limit the downstream burden, but it remains something to be aware of before getting any chest CT. The follow-up imaging triggered by an incidental nodule, unlike the CAC scan itself, is generally covered by Medicare because it falls under diagnostic evaluation of a potential abnormality.
The Advocacy Push for Coverage
Professional cardiology and radiology organizations have been lobbying for broader CAC coverage for years. The earlier CMS attempt to issue a blanket noncoverage decision was beaten back precisely because the clinical evidence supporting the test’s value is strong.2Elsevier / ScienceDirect (Journal of the American College of Radiology). Cardiac CT and Coronary CTA: Early Medicare Claims Analysis of National and Regional Utilization and Coverage Still, the USPSTF’s “insufficient evidence” rating remains the primary bottleneck, and that rating will not change until randomized trial data demonstrate that CAC-guided prevention strategies reduce hard clinical endpoints like heart attacks and deaths compared to standard care. Observational data, no matter how consistent, occupies a lower rung on the evidence ladder that the task force uses.
Recent publications have argued that the failure to cover CAC imaging leads to underdiagnosis and missed opportunities to prevent costly cardiovascular events, effectively shifting costs downstream in the form of emergency room visits, hospitalizations, and procedures that dwarf the price of a screening scan. Whether that economic argument will eventually move the coverage needle remains to be seen. For now, the most realistic path for Medicare beneficiaries who want a CAC scan is to discuss it with their doctor, understand that it will likely be an out-of-pocket expense, and weigh that modest cost against the potentially substantial value of knowing their personal plaque burden.